Phase 2 Retinal Vein Occlusion Clinical Trials
6 recruitingPhase 2
What is a Phase 2 trial?
Phase 2 trials evaluate whether a treatment works for a specific condition and further assess its safety. These studies typically enroll several hundred participants and provide preliminary data on effectiveness.
Showing 1–6 of 6 trials
Recruiting
Phase 2
Safety and Proof of Concept Study of ANXV (Annexin A5) in Patients With Diabetic Retinopathy or Retinal Vein Occlusion
Non-Proliferative Diabetic RetinopathyRetinal Vein Occlusion
Annexin Pharmaceuticals AB12 enrolled1 locationNCT07259928
Recruiting
Phase 2
A Dose-masked Study of Intravitreal EYE103 in Participants With NVAMD or Macular Edema Following BRVO
Neovascular Age-Related Macular Degeneration (NVAMD)Branch Retinal Vein Occlusion (BRVO)
EyeBiotech Ltd.160 enrolled49 locationsNCT07205887
Completed
Phase 2
Safety and efficacy of intra-vitreal bevacizumab combined with supra-choroidal triamcinolone in the treatment of central retinal vein occlusion.
Central retinal vein occlusion
Salahuddin34 enrolled1 locationACTRN12622000267752
Terminated
Phase 2
Tenecteplase in the acute management of branch retinal vein occlusion.
Branch retinal vein occlusion.
Lions Eye Institute40 enrolled2 locationsACTRN12615000185561
Recruiting
Phase 2
Bevacizumab intravitreal injection in the treatment of patients with Central Retinal Vein Occlusion.
Central retinal vein occlusion (CRVO)
Royal Adelaide Hospital22 enrolled1 locationACTRN12611000300976
Completed
Phase 2
The Efficacy and Safety of Treatment with Intravitreal Ranibizumab in Patients with Branch Retinal Vein Occlusion.
Macula oedema secondary to Branch Retinal Vein Occlusion.
Associate Professor Ian McAllister40 enrolled1 locationACTRN12607000262404